A Study of TY-302 in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of TY-302
single and the combination with Tamoxifen in dose-escalation and dose-expansion study.The
drugs involved in this study are:
- TY-302
- Tamoxifen